Inhibition of metastatic tumor formation in vivo by a bacteriophage display-derived galectin-3 targeting peptide

Inhibition of Prostate Cancer Bone Metastasis by Synthetic TF Antigen Mimic/Galectin-3 Inhibitor Lactulose-l-Leucine

(2015) Olga V. Glinskii et al.   NEOPLASIA

Diagnostic Utility of Galectin-3 in Thyroid Cancer

(2010) Connie G. Chiu et al.   AMERICAN JOURNAL OF PATHOLOGY

Targeted Therapies for Solid Tumors

(2010) Archontoula Stoffel   BIODRUGS

Phage Display in Molecular Imaging and Diagnosis of Cancer

(2010) Susan L. Deutscher   CHEMICAL REVIEWS

Galectin-3 Expression in Uterine Endometrioid Adenocarcinoma

(2010) Colin J.R. Stewart et al.   INTERNATIONAL JOURNAL OF GYNECOLOGICAL PATHOLOGY

Interaction between circulating galectin-3 and cancer-associated MUC1 enhances tumour cell homotypic aggregation and prevents anoikis

(2010) Qicheng Zhao et al.   Molecular Cancer

Clinicopathlogic and Immunohistochemical Characteristics of Triple Negative Invasive Lobular Carcinoma

(2010) Ja Seung Koo et al.   YONSEI MEDICAL JOURNAL

Somatostatin Receptor-Targeted Anti-Cancer Therapy

(2010) Li-Chun Sun et al.   Current Drug Delivery

Genetic Link Between Cancer and Thrombosis

(2009) Carla Boccaccio et al.   JOURNAL OF CLINICAL ONCOLOGY

Galectin-3 Expression in Tumor Progression and Metastasis of Papillary Thyroid Carcinoma

(2008) Hüseyin K. Türköz et al.   ENDOCRINE PATHOLOGY

111In-Labeled Galectin-3-Targeting Peptide as a SPECT Agent for Imaging Breast Tumors

(2008) S. R. Kumar et al.   JOURNAL OF NUCLEAR MEDICINE

Peptide-Based Probes for Cancer Imaging

(2008) J. C. Reubi et al.   JOURNAL OF NUCLEAR MEDICINE